Sayson, Judito, JR.. S.
HRN: 25-25-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2024
CEFTRIAXONE 1G (VIAL)
06/07/2024
06/14/2024
IVT
1g
Q12
Fracture, Closed, Displaced M/3rd Femur, Right With Soft Tissue Injury Sec To MVA
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes